BioGaia AB (publ) reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SEK 369.8 million compared to SEK 365.82 million a year ago. Net income was SEK 121.85 million compared to SEK 115.95 million a year ago.

Basic earnings per share from continuing operations was SEK 1.21 compared to SEK 1.15 a year ago. Diluted earnings per share from continuing operations was SEK 1.21 compared to SEK 1.15 a year ago.